Juvenile Idiopathic Arthritis
Teenagers with juvenile idiopathic arthritis and their parents enjoyed participating in an internet-based intervention designed to improve accessibility and disease self-management.
Patients with juvenile idiopathic arthritis receiving biologic therapy have high rates of serious infections.
Technological advances can be helpful in juvenile idiopathic arthritis and are particularly well suited to younger people in general, who are more comfortable with device technologies and more likely to adopt them.
In patients with juvenile idiopathic arthritis, levels of serum vitamin D are closely related to cholesterol levels and other risk factors for cardiovascular disease.
Children with juvenile idiopathic arthritis using anti-TNFIs have a significantly higher risk for infection compared with children using DMARDs.
Clinical Pain Advisor Articles
- Trigger Point Injections, Pulsed Radiofrequency for Abdominal Myofascial Pain Syndrome
- Safety, Efficacy of Lidocaine Infusion for Prolonged Neuropathic Pain
- Assessing the Efficacy of Low-Dose Amitriptyline for Idiopathic Chronic Neck Pain
- CBT vs Pain Education for Chronic Pain in Low-Income Clinics
- Trigger Point Dry Needling Plus Exercise Cost-Effective for Subacromial Pain Syndrome
- Exploring the Connections Between Neuropathic Pain and Comorbid Mood Disorders
- Medical Marijuana Laws, Dispensaries May Reduce Deaths From Opioid Overdose
- Ketamine Infusion May Be Effective for the Short-Term Relief of CRPS-Associated Pain
- An Avenue for the Development of Opioid Adjuncts for Enhanced Analgesia, Reduced Abuse Potential
- Spinal Manipulative Therapy May Effectively Reduce Cervicogenic Headache Days
- Chronic Pain in Adolescents and Alexithymia
- Bedside Quantitative Sensory Testing May Reliably Assess Sensory Profiles in Neuropathic Pain
- Peripheral Neuropathy Management in the Primary Care Setting: A Guide
- The Link Between Medical Malpractice and Defensive Medicine
- Drug Copayments Often Exceed Prescription Drug Costs